aluates Reports

$ 0.0

Automative

Global Therapies and Diagnostics for Ovarian Cancer Market Insights, Forecast to 2030

Published Date: December 2024

Report Code: QYRE-Auto-5U18800

BUY CHAPTERS

Global Therapies and Diagnostics for Ovarian Cancer Market Insights, Forecast to 2030

Code: QYRE-Auto-5U18800

Report

December 2024

Pages:112

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Astra Zeneca

Clovis Oncology

Myriad

Tesaro

AbbVie

Celgene

Janssen Pharmaceuticals

Merck

Novartis

Quest Diagnostics Inc.

Therapies and Diagnostics for Ovarian Cancer Market Size

The global Therapies and Diagnostics for Ovarian Cancer market is projected to grow from US$ 2144.5 million in 2024 to US$ 2713.5 million by 2030, at a Compound Annual Growth Rate (CAGR) of 4.0% during the forecast period.

Therapies and Diagnostics for Ovarian Cancer Market

Ovarian cancer (ovarian cancer) accounts for 2.4% ~ 6.5% of the common malignant tumors in women, and ranks the third among the cancers of the female reproductive system, secondary to cervical cancer and uterine body cancer.In recent years, due to the prevention and treatment of cervical cancer and uterine body cancer, some achievements have been made, while the prevention and treatment of ovarian cancer is relatively small.So ovarian cancer is the leading cause of death among cancers of the reproductive system in women.

Market Analysis and Insights: Global Therapies and Diagnostics for Ovarian Cancer Market

The US & Canada market for Therapies and Diagnostics for Ovarian Cancer is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Therapies and Diagnostics for Ovarian Cancer is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The Europe market for Therapies and Diagnostics for Ovarian Cancer is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The global key companies of Therapies and Diagnostics for Ovarian Cancer include Astra Zeneca, Clovis Oncology, Myriad, TESARO, AbbVie Inc, Celgene, Janssen Pharmaceuticals, Merck and Novartis AG, etc. In 2023, the global top five players had a share approximately % in terms of revenue.

Therapies and Diagnostics for Ovarian Cancer is widely used in various fields, such as Hospitals, Clinics and Others,, etc. Hospitals provides greatest supports to the Therapies and Diagnostics for Ovarian Cancer industry development. In 2023, global % revenue of Therapies and Diagnostics for Ovarian Cancer went into Hospitals filed and the proportion will reach to % in 2030.

Report Covers:

This report presents an overview of global market for Therapies and Diagnostics for Ovarian Cancer market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Therapies and Diagnostics for Ovarian Cancer, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Therapies and Diagnostics for Ovarian Cancer, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Therapies and Diagnostics for Ovarian Cancer revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Therapies and Diagnostics for Ovarian Cancer market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Therapies and Diagnostics for Ovarian Cancer revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Therapies and Diagnostics for Ovarian Cancer Market Report

Report Metric	Details
Report Name	Therapies and Diagnostics for Ovarian Cancer Market
Accounted market size in 2024	US$ 2144.5 million
Forecasted market size in 2030	US$ 2713.5 million
CAGR	4.0
Base Year	2024
Forecasted years	2025 - 2030
Segment by Type	Surgery Radiation Therapy Drug Treatment
Segment by Application	Hospitals Clinics Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Astra Zeneca, Clovis Oncology, Myriad, TESARO, AbbVie Inc, Celgene, Janssen Pharmaceuticals, Merck, Novartis AG, Quest Diagnostics Inc
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Therapies and Diagnostics for Ovarian Cancer in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Therapies and Diagnostics for Ovarian Cancer companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Therapies and Diagnostics for Ovarian Cancer revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Therapies and Diagnostics for Ovarian Cancer Market growing?

Ans: The Therapies and Diagnostics for Ovarian Cancer Market witnessing a CAGR of 4.0 during the forecast period 2025-2030.

What is the Therapies and Diagnostics for Ovarian Cancer Market size in 2030?

Ans: The Therapies and Diagnostics for Ovarian Cancer Market size in 2030 will be US$ 2713.5 million.

Who are the main players in the Therapies and Diagnostics for Ovarian Cancer Market report?

Ans: The main players in the Therapies and Diagnostics for Ovarian Cancer Market are Astra Zeneca, Clovis Oncology, Myriad, TESARO, AbbVie Inc, Celgene, Janssen Pharmaceuticals, Merck, Novartis AG, Quest Diagnostics Inc

What are the Application segmentation covered in the Therapies and Diagnostics for Ovarian Cancer Market report?

Ans: The Applications covered in the Therapies and Diagnostics for Ovarian Cancer Market report are Hospitals, Clinics, Others

What are the Type segmentation covered in the Therapies and Diagnostics for Ovarian Cancer Market report?

Ans: The Types covered in the Therapies and Diagnostics for Ovarian Cancer Market report are Surgery, Radiation Therapy, Drug Treatment

Recommended Reports

Gynecological Cancer Markets

Cancer Diagnostics

Cancer Therapies

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Therapies and Diagnostics for Ovarian Cancer Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Surgery

1.2.3 Radiation Therapy

1.2.4 Drug Treatment

1.3 Market by Application

1.3.1 Global Therapies and Diagnostics for Ovarian Cancer Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Therapies and Diagnostics for Ovarian Cancer Market Perspective (2019-2030)

2.2 Global Therapies and Diagnostics for Ovarian Cancer Growth Trends by Region

2.2.1 Therapies and Diagnostics for Ovarian Cancer Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Therapies and Diagnostics for Ovarian Cancer Historic Market Size by Region (2019-2024)

2.2.3 Therapies and Diagnostics for Ovarian Cancer Forecasted Market Size by Region (2025-2030)

2.3 Therapies and Diagnostics for Ovarian Cancer Market Dynamics

2.3.1 Therapies and Diagnostics for Ovarian Cancer Industry Trends

2.3.2 Therapies and Diagnostics for Ovarian Cancer Market Drivers

2.3.3 Therapies and Diagnostics for Ovarian Cancer Market Challenges

2.3.4 Therapies and Diagnostics for Ovarian Cancer Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Therapies and Diagnostics for Ovarian Cancer by Players

3.1.1 Global Therapies and Diagnostics for Ovarian Cancer Revenue by Players (2019-2024)

3.1.2 Global Therapies and Diagnostics for Ovarian Cancer Revenue Market Share by Players (2019-2024)

3.2 Global Therapies and Diagnostics for Ovarian Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Therapies and Diagnostics for Ovarian Cancer, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Therapies and Diagnostics for Ovarian Cancer Market Concentration Ratio

3.4.1 Global Therapies and Diagnostics for Ovarian Cancer Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Therapies and Diagnostics for Ovarian Cancer Revenue in 2023

3.5 Global Key Players of Therapies and Diagnostics for Ovarian Cancer Head office and Area Served

3.6 Global Key Players of Therapies and Diagnostics for Ovarian Cancer, Product and Application

3.7 Global Key Players of Therapies and Diagnostics for Ovarian Cancer, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Therapies and Diagnostics for Ovarian Cancer Breakdown Data by Type

4.1 Global Therapies and Diagnostics for Ovarian Cancer Historic Market Size by Type (2019-2024)

4.2 Global Therapies and Diagnostics for Ovarian Cancer Forecasted Market Size by Type (2025-2030)

5 Therapies and Diagnostics for Ovarian Cancer Breakdown Data by Application

5.1 Global Therapies and Diagnostics for Ovarian Cancer Historic Market Size by Application (2019-2024)

5.2 Global Therapies and Diagnostics for Ovarian Cancer Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Therapies and Diagnostics for Ovarian Cancer Market Size (2019-2030)

6.2 North America Therapies and Diagnostics for Ovarian Cancer Market Size by Type

6.2.1 North America Therapies and Diagnostics for Ovarian Cancer Market Size by Type (2019-2024)

6.2.2 North America Therapies and Diagnostics for Ovarian Cancer Market Size by Type (2025-2030)

6.2.3 North America Therapies and Diagnostics for Ovarian Cancer Market Share by Type (2019-2030)

6.3 North America Therapies and Diagnostics for Ovarian Cancer Market Size by Application

6.3.1 North America Therapies and Diagnostics for Ovarian Cancer Market Size by Application (2019-2024)

6.3.2 North America Therapies and Diagnostics for Ovarian Cancer Market Size by Application (2025-2030)

6.3.3 North America Therapies and Diagnostics for Ovarian Cancer Market Share by Application (2019-2030)

6.4 North America Therapies and Diagnostics for Ovarian Cancer Market Size by Country

6.4.1 North America Therapies and Diagnostics for Ovarian Cancer Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Therapies and Diagnostics for Ovarian Cancer Market Size by Country (2019-2024)

6.4.3 North America Therapies and Diagnostics for Ovarian Cancer Market Size by Country (2025-2030)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Therapies and Diagnostics for Ovarian Cancer Market Size (2019-2030)

7.2 Europe Therapies and Diagnostics for Ovarian Cancer Market Size by Type

7.2.1 Europe Therapies and Diagnostics for Ovarian Cancer Market Size by Type (2019-2024)

7.2.2 Europe Therapies and Diagnostics for Ovarian Cancer Market Size by Type (2025-2030)

7.2.3 Europe Therapies and Diagnostics for Ovarian Cancer Market Share by Type (2019-2030)

7.3 Europe Therapies and Diagnostics for Ovarian Cancer Market Size by Application

7.3.1 Europe Therapies and Diagnostics for Ovarian Cancer Market Size by Application (2019-2024)

7.3.2 Europe Therapies and Diagnostics for Ovarian Cancer Market Size by Application (2025-2030)

7.3.3 Europe Therapies and Diagnostics for Ovarian Cancer Market Share by Application (2019-2030)

7.4 Europe Therapies and Diagnostics for Ovarian Cancer Market Size by Country

7.4.1 Europe Therapies and Diagnostics for Ovarian Cancer Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Therapies and Diagnostics for Ovarian Cancer Market Size by Country (2019-2024)

7.4.3 Europe Therapies and Diagnostics for Ovarian Cancer Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Therapies and Diagnostics for Ovarian Cancer Market Size (2019-2030)

8.2 China Therapies and Diagnostics for Ovarian Cancer Market Size by Type

8.2.1 China Therapies and Diagnostics for Ovarian Cancer Market Size by Type (2019-2024)

8.2.2 China Therapies and Diagnostics for Ovarian Cancer Market Size by Type (2025-2030)

8.2.3 China Therapies and Diagnostics for Ovarian Cancer Market Share by Type (2019-2030)

8.3 China Therapies and Diagnostics for Ovarian Cancer Market Size by Application

8.3.1 China Therapies and Diagnostics for Ovarian Cancer Market Size by Application (2019-2024)

8.3.2 China Therapies and Diagnostics for Ovarian Cancer Market Size by Application (2025-2030)

8.3.3 China Therapies and Diagnostics for Ovarian Cancer Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Therapies and Diagnostics for Ovarian Cancer Market Size (2019-2030)

9.2 Asia Therapies and Diagnostics for Ovarian Cancer Market Size by Type

9.2.1 Asia Therapies and Diagnostics for Ovarian Cancer Market Size by Type (2019-2024)

9.2.2 Asia Therapies and Diagnostics for Ovarian Cancer Market Size by Type (2025-2030)

9.2.3 Asia Therapies and Diagnostics for Ovarian Cancer Market Share by Type (2019-2030)

9.3 Asia Therapies and Diagnostics for Ovarian Cancer Market Size by Application

9.3.1 Asia Therapies and Diagnostics for Ovarian Cancer Market Size by Application (2019-2024)

9.3.2 Asia Therapies and Diagnostics for Ovarian Cancer Market Size by Application (2025-2030)

9.3.3 Asia Therapies and Diagnostics for Ovarian Cancer Market Share by Application (2019-2030)

9.4 Asia Therapies and Diagnostics for Ovarian Cancer Market Size by Region

9.4.1 Asia Therapies and Diagnostics for Ovarian Cancer Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Therapies and Diagnostics for Ovarian Cancer Market Size by Region (2019-2024)

9.4.3 Asia Therapies and Diagnostics for Ovarian Cancer Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Therapies and Diagnostics for Ovarian Cancer Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Therapies and Diagnostics for Ovarian Cancer Market Size by Type

10.2.1 Middle East, Africa, and Latin America Therapies and Diagnostics for Ovarian Cancer Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Therapies and Diagnostics for Ovarian Cancer Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Therapies and Diagnostics for Ovarian Cancer Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Therapies and Diagnostics for Ovarian Cancer Market Size by Application

10.3.1 Middle East, Africa, and Latin America Therapies and Diagnostics for Ovarian Cancer Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Therapies and Diagnostics for Ovarian Cancer Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Therapies and Diagnostics for Ovarian Cancer Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Therapies and Diagnostics for Ovarian Cancer Market Size by Country

10.4.1 Middle East, Africa, and Latin America Therapies and Diagnostics for Ovarian Cancer Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Therapies and Diagnostics for Ovarian Cancer Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Therapies and Diagnostics for Ovarian Cancer Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Astra Zeneca

11.1.1 Astra Zeneca Company Details

11.1.2 Astra Zeneca Business Overview

11.1.3 Astra Zeneca Therapies and Diagnostics for Ovarian Cancer Introduction

11.1.4 Astra Zeneca Revenue in Therapies and Diagnostics for Ovarian Cancer Business (2019-2024)

11.1.5 Astra Zeneca Recent Developments

11.2 Clovis Oncology

11.2.1 Clovis Oncology Company Details

11.2.2 Clovis Oncology Business Overview

11.2.3 Clovis Oncology Therapies and Diagnostics for Ovarian Cancer Introduction

11.2.4 Clovis Oncology Revenue in Therapies and Diagnostics for Ovarian Cancer Business (2019-2024)

11.2.5 Clovis Oncology Recent Developments

11.3 Myriad

11.3.1 Myriad Company Details

11.3.2 Myriad Business Overview

11.3.3 Myriad Therapies and Diagnostics for Ovarian Cancer Introduction

11.3.4 Myriad Revenue in Therapies and Diagnostics for Ovarian Cancer Business (2019-2024)

11.3.5 Myriad Recent Developments

11.4 TESARO

11.4.1 TESARO Company Details

11.4.2 TESARO Business Overview

11.4.3 TESARO Therapies and Diagnostics for Ovarian Cancer Introduction

11.4.4 TESARO Revenue in Therapies and Diagnostics for Ovarian Cancer Business (2019-2024)

11.4.5 TESARO Recent Developments

11.5 AbbVie Inc

11.5.1 AbbVie Inc Company Details

11.5.2 AbbVie Inc Business Overview

11.5.3 AbbVie Inc Therapies and Diagnostics for Ovarian Cancer Introduction

11.5.4 AbbVie Inc Revenue in Therapies and Diagnostics for Ovarian Cancer Business (2019-2024)

11.5.5 AbbVie Inc Recent Developments

11.6 Celgene

11.6.1 Celgene Company Details

11.6.2 Celgene Business Overview

11.6.3 Celgene Therapies and Diagnostics for Ovarian Cancer Introduction

11.6.4 Celgene Revenue in Therapies and Diagnostics for Ovarian Cancer Business (2019-2024)

11.6.5 Celgene Recent Developments

11.7 Janssen Pharmaceuticals

11.7.1 Janssen Pharmaceuticals Company Details

11.7.2 Janssen Pharmaceuticals Business Overview

11.7.3 Janssen Pharmaceuticals Therapies and Diagnostics for Ovarian Cancer Introduction

11.7.4 Janssen Pharmaceuticals Revenue in Therapies and Diagnostics for Ovarian Cancer Business (2019-2024)

11.7.5 Janssen Pharmaceuticals Recent Developments

11.8 Merck

11.8.1 Merck Company Details

11.8.2 Merck Business Overview

11.8.3 Merck Therapies and Diagnostics for Ovarian Cancer Introduction

11.8.4 Merck Revenue in Therapies and Diagnostics for Ovarian Cancer Business (2019-2024)

11.8.5 Merck Recent Developments

11.9 Novartis AG

11.9.1 Novartis AG Company Details

11.9.2 Novartis AG Business Overview

11.9.3 Novartis AG Therapies and Diagnostics for Ovarian Cancer Introduction

11.9.4 Novartis AG Revenue in Therapies and Diagnostics for Ovarian Cancer Business (2019-2024)

11.9.5 Novartis AG Recent Developments

11.10 Quest Diagnostics Inc

11.10.1 Quest Diagnostics Inc Company Details

11.10.2 Quest Diagnostics Inc Business Overview

11.10.3 Quest Diagnostics Inc Therapies and Diagnostics for Ovarian Cancer Introduction

11.10.4 Quest Diagnostics Inc Revenue in Therapies and Diagnostics for Ovarian Cancer Business (2019-2024)

11.10.5 Quest Diagnostics Inc Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Astra Zeneca

Clovis Oncology

Myriad

Tesaro

AbbVie

Celgene

Janssen Pharmaceuticals

Merck

Novartis

Quest Diagnostics Inc.

List of Tables

Table 1. Global Therapies and Diagnostics for Ovarian Cancer Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of Surgery

Table 3. Key Players of Radiation Therapy

Table 4. Key Players of Drug Treatment

Table 5. Global Therapies and Diagnostics for Ovarian Cancer Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 6. Global Therapies and Diagnostics for Ovarian Cancer Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Therapies and Diagnostics for Ovarian Cancer Market Size by Region (2019-2024) & (US$ Million)

Table 8. Global Therapies and Diagnostics for Ovarian Cancer Market Share by Region (2019-2024)

Table 9. Global Therapies and Diagnostics for Ovarian Cancer Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 10. Global Therapies and Diagnostics for Ovarian Cancer Market Share by Region (2025-2030)

Table 11. Therapies and Diagnostics for Ovarian Cancer Market Trends

Table 12. Therapies and Diagnostics for Ovarian Cancer Market Drivers

Table 13. Therapies and Diagnostics for Ovarian Cancer Market Challenges

Table 14. Therapies and Diagnostics for Ovarian Cancer Market Restraints

Table 15. Global Therapies and Diagnostics for Ovarian Cancer Revenue by Players (2019-2024) & (US$ Million)

Table 16. Global Therapies and Diagnostics for Ovarian Cancer Revenue Share by Players (2019-2024)

Table 17. Global Top Therapies and Diagnostics for Ovarian Cancer by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Therapies and Diagnostics for Ovarian Cancer as of 2023)

Table 18. Global Therapies and Diagnostics for Ovarian Cancer Industry Ranking 2022 VS 2023 VS 2024

Table 19. Global 5 Largest Players Market Share by Therapies and Diagnostics for Ovarian Cancer Revenue (CR5 and HHI) & (2019-2024)

Table 20. Global Key Players of Therapies and Diagnostics for Ovarian Cancer, Headquarters and Area Served

Table 21. Global Key Players of Therapies and Diagnostics for Ovarian Cancer, Product and Application

Table 22. Global Key Players of Therapies and Diagnostics for Ovarian Cancer, Product and Application

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Therapies and Diagnostics for Ovarian Cancer Market Size by Type (2019-2024) & (US$ Million)

Table 25. Global Therapies and Diagnostics for Ovarian Cancer Revenue Market Share by Type (2019-2024)

Table 26. Global Therapies and Diagnostics for Ovarian Cancer Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 27. Global Therapies and Diagnostics for Ovarian Cancer Revenue Market Share by Type (2025-2030)

Table 28. Global Therapies and Diagnostics for Ovarian Cancer Market Size by Application (2019-2024) & (US$ Million)

Table 29. Global Therapies and Diagnostics for Ovarian Cancer Revenue Share by Application (2019-2024)

Table 30. Global Therapies and Diagnostics for Ovarian Cancer Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 31. Global Therapies and Diagnostics for Ovarian Cancer Revenue Share by Application (2025-2030)

Table 32. North America Therapies and Diagnostics for Ovarian Cancer Market Size by Type (2019-2024) & (US$ Million)

Table 33. North America Therapies and Diagnostics for Ovarian Cancer Market Size by Type (2025-2030) & (US$ Million)

Table 34. North America Therapies and Diagnostics for Ovarian Cancer Market Size by Application (2019-2024) & (US$ Million)

Table 35. North America Therapies and Diagnostics for Ovarian Cancer Market Size by Application (2025-2030) & (US$ Million)

Table 36. North America Therapies and Diagnostics for Ovarian Cancer Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 37. North America Therapies and Diagnostics for Ovarian Cancer Market Size by Country (2019-2024) & (US$ Million)

Table 38. North America Therapies and Diagnostics for Ovarian Cancer Market Size by Country (2025-2030) & (US$ Million)

Table 39. Europe Therapies and Diagnostics for Ovarian Cancer Market Size by Type (2019-2024) & (US$ Million)

Table 40. Europe Therapies and Diagnostics for Ovarian Cancer Market Size by Type (2025-2030) & (US$ Million)

Table 41. Europe Therapies and Diagnostics for Ovarian Cancer Market Size by Application (2019-2024) & (US$ Million)

Table 42. Europe Therapies and Diagnostics for Ovarian Cancer Market Size by Application (2025-2030) & (US$ Million)

Table 43. Europe Therapies and Diagnostics for Ovarian Cancer Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Europe Therapies and Diagnostics for Ovarian Cancer Market Size by Country (2019-2024) & (US$ Million)

Table 45. Europe Therapies and Diagnostics for Ovarian Cancer Market Size by Country (2025-2030) & (US$ Million)

Table 46. China Therapies and Diagnostics for Ovarian Cancer Market Size by Type (2019-2024) & (US$ Million)

Table 47. China Therapies and Diagnostics for Ovarian Cancer Market Size by Type (2025-2030) & (US$ Million)

Table 48. China Therapies and Diagnostics for Ovarian Cancer Market Size by Application (2019-2024) & (US$ Million)

Table 49. China Therapies and Diagnostics for Ovarian Cancer Market Size by Application (2025-2030) & (US$ Million)

Table 50. Asia Therapies and Diagnostics for Ovarian Cancer Market Size by Type (2019-2024) & (US$ Million)

Table 51. Asia Therapies and Diagnostics for Ovarian Cancer Market Size by Type (2025-2030) & (US$ Million)

Table 52. Asia Therapies and Diagnostics for Ovarian Cancer Market Size by Application (2019-2024) & (US$ Million)

Table 53. Asia Therapies and Diagnostics for Ovarian Cancer Market Size by Application (2025-2030) & (US$ Million)

Table 54. Asia Therapies and Diagnostics for Ovarian Cancer Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 55. Asia Therapies and Diagnostics for Ovarian Cancer Market Size by Region (2019-2024) & (US$ Million)

Table 56. Asia Therapies and Diagnostics for Ovarian Cancer Market Size by Region (2025-2030) & (US$ Million)

Table 57. Middle East, Africa, and Latin America Therapies and Diagnostics for Ovarian Cancer Market Size by Type (2019-2024) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Therapies and Diagnostics for Ovarian Cancer Market Size by Type (2025-2030) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Therapies and Diagnostics for Ovarian Cancer Market Size by Application (2019-2024) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Therapies and Diagnostics for Ovarian Cancer Market Size by Application (2025-2030) & (US$ Million)

Table 61. Middle East, Africa, and Latin America Therapies and Diagnostics for Ovarian Cancer Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 62. Middle East, Africa, and Latin America Therapies and Diagnostics for Ovarian Cancer Market Size by Country (2019-2024) & (US$ Million)

Table 63. Middle East, Africa, and Latin America Therapies and Diagnostics for Ovarian Cancer Market Size by Country (2025-2030) & (US$ Million)

Table 64. Astra Zeneca Company Details

Table 65. Astra Zeneca Business Overview

Table 66. Astra Zeneca Therapies and Diagnostics for Ovarian Cancer Product

Table 67. Astra Zeneca Revenue in Therapies and Diagnostics for Ovarian Cancer Business (2019-2024) & (US$ Million)

Table 68. Astra Zeneca Recent Developments

Table 69. Clovis Oncology Company Details

Table 70. Clovis Oncology Business Overview

Table 71. Clovis Oncology Therapies and Diagnostics for Ovarian Cancer Product

Table 72. Clovis Oncology Revenue in Therapies and Diagnostics for Ovarian Cancer Business (2019-2024) & (US$ Million)

Table 73. Clovis Oncology Recent Developments

Table 74. Myriad Company Details

Table 75. Myriad Business Overview

Table 76. Myriad Therapies and Diagnostics for Ovarian Cancer Product

Table 77. Myriad Revenue in Therapies and Diagnostics for Ovarian Cancer Business (2019-2024) & (US$ Million)

Table 78. Myriad Recent Developments

Table 79. TESARO Company Details

Table 80. TESARO Business Overview

Table 81. TESARO Therapies and Diagnostics for Ovarian Cancer Product

Table 82. TESARO Revenue in Therapies and Diagnostics for Ovarian Cancer Business (2019-2024) & (US$ Million)

Table 83. TESARO Recent Developments

Table 84. AbbVie Inc Company Details

Table 85. AbbVie Inc Business Overview

Table 86. AbbVie Inc Therapies and Diagnostics for Ovarian Cancer Product

Table 87. AbbVie Inc Revenue in Therapies and Diagnostics for Ovarian Cancer Business (2019-2024) & (US$ Million)

Table 88. AbbVie Inc Recent Developments

Table 89. Celgene Company Details

Table 90. Celgene Business Overview

Table 91. Celgene Therapies and Diagnostics for Ovarian Cancer Product

Table 92. Celgene Revenue in Therapies and Diagnostics for Ovarian Cancer Business (2019-2024) & (US$ Million)

Table 93. Celgene Recent Developments

Table 94. Janssen Pharmaceuticals Company Details

Table 95. Janssen Pharmaceuticals Business Overview

Table 96. Janssen Pharmaceuticals Therapies and Diagnostics for Ovarian Cancer Product

Table 97. Janssen Pharmaceuticals Revenue in Therapies and Diagnostics for Ovarian Cancer Business (2019-2024) & (US$ Million)

Table 98. Janssen Pharmaceuticals Recent Developments

Table 99. Merck Company Details

Table 100. Merck Business Overview

Table 101. Merck Therapies and Diagnostics for Ovarian Cancer Product

Table 102. Merck Revenue in Therapies and Diagnostics for Ovarian Cancer Business (2019-2024) & (US$ Million)

Table 103. Merck Recent Developments

Table 104. Novartis AG Company Details

Table 105. Novartis AG Business Overview

Table 106. Novartis AG Therapies and Diagnostics for Ovarian Cancer Product

Table 107. Novartis AG Revenue in Therapies and Diagnostics for Ovarian Cancer Business (2019-2024) & (US$ Million)

Table 108. Novartis AG Recent Developments

Table 109. Quest Diagnostics Inc Company Details

Table 110. Quest Diagnostics Inc Business Overview

Table 111. Quest Diagnostics Inc Therapies and Diagnostics for Ovarian Cancer Product

Table 112. Quest Diagnostics Inc Revenue in Therapies and Diagnostics for Ovarian Cancer Business (2019-2024) & (US$ Million)

Table 113. Quest Diagnostics Inc Recent Developments

Table 114. Research Programs/Design for This Report

Table 115. Key Data Information from Secondary Sources

Table 116. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Therapies and Diagnostics for Ovarian Cancer Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Therapies and Diagnostics for Ovarian Cancer Market Share by Type: 2023 VS 2030

Figure 3. Surgery Features

Figure 4. Radiation Therapy Features

Figure 5. Drug Treatment Features

Figure 6. Global Therapies and Diagnostics for Ovarian Cancer Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 7. Global Therapies and Diagnostics for Ovarian Cancer Market Share by Application: 2023 VS 2030

Figure 8. Hospitals Case Studies

Figure 9. Clinics Case Studies

Figure 10. Others Case Studies

Figure 11. Therapies and Diagnostics for Ovarian Cancer Report Years Considered

Figure 12. Global Therapies and Diagnostics for Ovarian Cancer Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 13. Global Therapies and Diagnostics for Ovarian Cancer Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Therapies and Diagnostics for Ovarian Cancer Market Share by Region: 2023 VS 2030

Figure 15. Global Therapies and Diagnostics for Ovarian Cancer Market Share by Players in 2023

Figure 16. Global Top Therapies and Diagnostics for Ovarian Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Therapies and Diagnostics for Ovarian Cancer as of 2023)

Figure 17. The Top 10 and 5 Players Market Share by Therapies and Diagnostics for Ovarian Cancer Revenue in 2023

Figure 18. North America Therapies and Diagnostics for Ovarian Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 19. North America Therapies and Diagnostics for Ovarian Cancer Market Share by Type (2019-2030)

Figure 20. North America Therapies and Diagnostics for Ovarian Cancer Market Share by Application (2019-2030)

Figure 21. North America Therapies and Diagnostics for Ovarian Cancer Market Share by Country (2019-2030)

Figure 22. United States Therapies and Diagnostics for Ovarian Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Canada Therapies and Diagnostics for Ovarian Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Therapies and Diagnostics for Ovarian Cancer Market Size YoY (2019-2030) & (US$ Million)

Figure 25. Europe Therapies and Diagnostics for Ovarian Cancer Market Share by Type (2019-2030)

Figure 26. Europe Therapies and Diagnostics for Ovarian Cancer Market Share by Application (2019-2030)

Figure 27. Europe Therapies and Diagnostics for Ovarian Cancer Market Share by Country (2019-2030)

Figure 28. Germany Therapies and Diagnostics for Ovarian Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. France Therapies and Diagnostics for Ovarian Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. U.K. Therapies and Diagnostics for Ovarian Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Italy Therapies and Diagnostics for Ovarian Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Russia Therapies and Diagnostics for Ovarian Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Nordic Countries Therapies and Diagnostics for Ovarian Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. China Therapies and Diagnostics for Ovarian Cancer Market Size YoY (2019-2030) & (US$ Million)

Figure 35. China Therapies and Diagnostics for Ovarian Cancer Market Share by Type (2019-2030)

Figure 36. China Therapies and Diagnostics for Ovarian Cancer Market Share by Application (2019-2030)

Figure 37. Asia Therapies and Diagnostics for Ovarian Cancer Market Size YoY (2019-2030) & (US$ Million)

Figure 38. Asia Therapies and Diagnostics for Ovarian Cancer Market Share by Type (2019-2030)

Figure 39. Asia Therapies and Diagnostics for Ovarian Cancer Market Share by Application (2019-2030)

Figure 40. Asia Therapies and Diagnostics for Ovarian Cancer Market Share by Region (2019-2030)

Figure 41. Japan Therapies and Diagnostics for Ovarian Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. South Korea Therapies and Diagnostics for Ovarian Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. China Taiwan Therapies and Diagnostics for Ovarian Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Southeast Asia Therapies and Diagnostics for Ovarian Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. India Therapies and Diagnostics for Ovarian Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Australia Therapies and Diagnostics for Ovarian Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Middle East, Africa, and Latin America Therapies and Diagnostics for Ovarian Cancer Market Size YoY (2019-2030) & (US$ Million)

Figure 48. Middle East, Africa, and Latin America Therapies and Diagnostics for Ovarian Cancer Market Share by Type (2019-2030)

Figure 49. Middle East, Africa, and Latin America Therapies and Diagnostics for Ovarian Cancer Market Share by Application (2019-2030)

Figure 50. Middle East, Africa, and Latin America Therapies and Diagnostics for Ovarian Cancer Market Share by Country (2019-2030)

Figure 51. Brazil Therapies and Diagnostics for Ovarian Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 52. Mexico Therapies and Diagnostics for Ovarian Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 53. Turkey Therapies and Diagnostics for Ovarian Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Saudi Arabia Therapies and Diagnostics for Ovarian Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. Israel Therapies and Diagnostics for Ovarian Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. GCC Countries Therapies and Diagnostics for Ovarian Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 57. Astra Zeneca Revenue Growth Rate in Therapies and Diagnostics for Ovarian Cancer Business (2019-2024)

Figure 58. Clovis Oncology Revenue Growth Rate in Therapies and Diagnostics for Ovarian Cancer Business (2019-2024)

Figure 59. Myriad Revenue Growth Rate in Therapies and Diagnostics for Ovarian Cancer Business (2019-2024)

Figure 60. TESARO Revenue Growth Rate in Therapies and Diagnostics for Ovarian Cancer Business (2019-2024)

Figure 61. AbbVie Inc Revenue Growth Rate in Therapies and Diagnostics for Ovarian Cancer Business (2019-2024)

Figure 62. Celgene Revenue Growth Rate in Therapies and Diagnostics for Ovarian Cancer Business (2019-2024)

Figure 63. Janssen Pharmaceuticals Revenue Growth Rate in Therapies and Diagnostics for Ovarian Cancer Business (2019-2024)

Figure 64. Merck Revenue Growth Rate in Therapies and Diagnostics for Ovarian Cancer Business (2019-2024)

Figure 65. Novartis AG Revenue Growth Rate in Therapies and Diagnostics for Ovarian Cancer Business (2019-2024)

Figure 66. Quest Diagnostics Inc Revenue Growth Rate in Therapies and Diagnostics for Ovarian Cancer Business (2019-2024)

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Ovarian Cancer Targeted Therapy Drugs Market Research Report 2024

Global Ovarian Cancer Drugs Market Insights Forecast to 2030

Global Uterine Cancer Therapies and Diagnostic Market Insights Forecast to 2030

Global Epithelial Ovarian Cancer Treatment Market Research Report 2024

Global Ovarian Cancer Molecular Diagnostics Market Research Report 2024

Global Gynecological Cancers Therapeutics Market Insights Forecast to 2030

Global Ovarian Cancer Market Research Report 2024

Global Women Health Diagnostics Market Insights Forecast to 2030

Gynecological Cancers Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Gynecological Cancer Diagnostics Market Research Report 2025

Global Fallopian Tube Cancer Therapeutics Market Insights Forecast to 2030

Gynaecological Cancer Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Cervical Cancer Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Ovarian Cancer Diagnostics and Therapeutics Market Insights Forecast to 2030

Global Women s Health Diagnostics Market Insights Forecast to 2030

Global Orthopedic Oncology Treatment Market Insights Forecast to 2030

Global Polycystic Ovarian Syndrome PCOS Therapeutics Market Insights Forecast to 2030

Global Next Generation Gynecological Cancer Diagnostics Market Research Report 2024

Testicular Cancer Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions